Brief: Talaris Therapeutics Shares Open At A Premium of 1.5% In Nasdaq Debut Vs IPO Price
07/05/2021 17:22
May 7 (Reuters) -
* TALARIS THERAPEUTICS INC SHARES OPEN AT $17.25 IN NASDAQ
DEBUT
VERSUS IPO PRICE OF $17/SHARE
Further company coverage: TALS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tourmaline Bio
See all newsBrief: Novartis Completes Acquisition Of Tourmaline Bio
Brief: Novartis Announces Expiration Of Tourmaline Bio Tender Offer
Novartis nears deal to acquire Avidity Biosciences for over $70 per share, Bloomberg News reports (updated)
Brief: Novartis Announces Commencement Of Tender Offer To Acquire Tourmaline Bio
U.S. STOCKS ON THE MOVE-Potbelly, Joby, Talen Energy